A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer

Ronan Joseph Kelly, Anish Thomas, Arun Rajan et al. · Annals of Oncology · 2013

Cited by 166 works. doi:10.1093/annonc/mdt249 Open-access PDF

Authors

References